Back to search
Major Adverse Cardiovascular Events
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Major Adverse Cardiovascular Events trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Major Adverse Cardiovascular Events trials you may qualify forVenous thromboembolism (VTE) and atherosclerotic cardiovascular disease share common risk factors and frequently coexist in the same patients. Their management…
DAN-ZOSTER is a nationwide randomized study investigating whether vaccination against herpes zoster (shingles) can reduce the risk of cardiovascular disease and…
The rationale of our study is to observe the incidence of MACE in RA patients treated with tofacitinib along with statins with one or more cardiovascular diseas…
The main purpose of the study is to evaluate the efficacy of selnoflast compared with placebo in participants with atherosclerosis, at high-risk for major adver…
Heart disease remains the leading cause of death in Veterans. Inflammation in the arteries of the heart may increase the risk of cardiac death. Patients with he…
The goal of this observational study is to develop and evaluate an artificial intelligence (AI)-based multimodal model for predicting major cardiovascular event…
In stent restenosis and myocardial infarction are have been linked the balance between injury and healing of the endothelium These processes can be measured res…
Determine the long-term efficacy of clopidogrel compared with aspirin in reducing heart or brain attacks in patients with stable heart disease